NMRA in the 13F filings

Neumora Therapeutics Inc. · CUSIP 640979100

Sector · Pharmaceuticals and biotechnology Theme · Biological products Theme · Healthcare: biopharma and medtech· L3VLUP-defined

Quarter

Q4 2024 Q3 2024 Q2 2024 Q3 2023

Quarter end: 31 Dec 2024; the date the book describes
Filed: 14 Feb 2025; latest of these filings; the earliest 14 Feb 2025
Managers listing it: 2; at least, of 95 tracked, among listed positions
Comparable managers: 94; filed both Q3 2024 and Q4 2024; 0 listed it in both
Shares listed: 601,572; combined, among listed positions
Reported value: $6.4m; combined, at the quarter end

Among the 94 comparable managers: 2 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing NMRA in Q4 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

ActionShare of book at least

2 of 2 holders

				Action		Filing
Schonfeld Strategic Advisors LLC	521,013	$5.5m	under 0.1%	Added	n.a.	14 Feb 2025 (the filing on sec.gov)
Brevan Howard Capital Management LP	80,559	$854k	under 0.1%	New	new	14 Feb 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2024 to Q4 2024, among managers that listed it in both quarters or opened it.

Increases

Brevan Howard Capital Management LPnew position · 80,559 shares now+80,559

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Brevan Howard Capital Management LP$854k

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.

1 in Q3 2023 to 2 in Q4 2024

Tracked managers listing it, at least.

the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

NMRA and GILD →NMRA and AMGN →NMRA and ARGX →Choose a stock to compare with NMRA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own NMRA, latest filings →Back to the 13F Explorer →

Provided for information purposes only, not financial advice. The holdings shown here and anything drawn from them are illustrative, produced from assumptions you control, and must not be relied on for any investment, financial or business decision. Read the full notice

Not advice, and not a recommendation. Everything L3VLUP publishes is provided for information purposes only. Nothing here is financial, investment, legal, tax or accounting advice, a personal recommendation, or an offer or solicitation to buy or sell any security or financial instrument. It takes no account of anyone’s objectives, financial situation or needs.

Not a regulated adviser. L3VLUP does not provide regulated financial services. Speak to a suitably qualified and regulated professional before acting on anything you read here.

Illustrative figures. Default values are plausible starting points chosen so a model has somewhere to begin. They are not data, not a view on any company, and not calibrated to anything. Outputs move with whatever you type in.

Third-party data. Where live figures appear they come from third parties, including public filings and market feeds. They may be delayed, incomplete, restated, mis-tagged at source or simply wrong, and their providers do not endorse or verify this page. Every figure links to where it came from. Check it there before relying on it. Past performance is not a guide to future performance.

Company names and logos. Names, tickers and logos are the trademarks of their owners and appear only to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, none of them took part in preparing the exercise, and nothing here is a statement by or about any of them. See third-party names and marks.

No warranty, and limited liability. This page is provided “as is” without warranty of any kind. To the fullest extent permitted by law, L3VLUP accepts no liability for any loss or damage arising from use of, or reliance on, anything on it. Nothing in this notice limits any liability that cannot lawfully be limited.

Full terms: Information Purposes and No Advice · Terms

Quarter	Holders	Reported value	Buyers	Sellers
Q3 2023	1	$141k	n.a.	n.a.
Q2 2024	1	$1.6m	1	0
Q3 2024	1	$4.1m	1	0
Q4 2024	2	$6.4m	2	0